Idiopathic photoreceptor dysfunction causes unexplained visual acuity loss in later adulthood.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 2087294)

Published in Ophthalmology on December 01, 1990

Authors

S E Rowe1, J D Trobe, P A Sieving

Author Affiliations

1: W. K. Kellogg Eye Center, Department of Ophthalmology, University of Michigan Medical Center, Ann Arbor 48105.

Articles by these authors

(truncated to the top 100)

Nrl is required for rod photoreceptor development. Nat Genet (2001) 5.68

Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat Genet (1997) 4.50

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med (1993) 4.34

A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet (2001) 3.52

Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol (1984) 2.90

Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci (2000) 2.46

Mutations in the cone-rod homeobox gene are associated with the cone-rod dystrophy photoreceptor degeneration. Neuron (1997) 2.34

P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci (2000) 2.23

Tarsorrhaphy from accidental instillation of cyanoacrylate adhesive in the eye. JAMA (1982) 2.20

A proximal retinal component in the primate photopic ERG a-wave. Invest Ophthalmol Vis Sci (1994) 1.85

Multiple evanescent white dot syndrome. II. Electrophysiology of the photoreceptors during retinal pigment epithelial disease. Arch Ophthalmol (1984) 1.82

Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystrophy. Nat Genet (2001) 1.81

Leber congenital amaurosis caused by a homozygous mutation (R90W) in the homeodomain of the retinal transcription factor CRX: direct evidence for the involvement of CRX in the development of photoreceptor function. Hum Mol Genet (1999) 1.80

Dysthyroid optic neuropathy. Clinical profile and rationale for management. Arch Ophthalmol (1978) 1.77

Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol (2000) 1.73

What we have learned from the Optic Neuritis Treatment Trial. Ophthalmology (1995) 1.71

The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol (1999) 1.62

Neuro-ophthalmic features of cerebral venous obstruction. Arch Neurol (1995) 1.61

Confrontation visual field techniques in the detection of anterior visual pathway lesions. Ann Neurol (1981) 1.59

Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse. Gene Ther (2009) 1.56

Bilateral retrobulbar optic nerve infarctions after blood loss and hypotension. A clinicopathologic case study. Ophthalmology (1987) 1.50

Ischemic optic neuropathy after lumbar spine surgery. Arch Ophthalmol (1994) 1.48

High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial. Arch Ophthalmol (1994) 1.46

Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa. Am J Hum Genet (1997) 1.45

Scotopic threshold response of proximal retina in cat. J Neurophysiol (1986) 1.45

Isolated homonymous hemianopia. A review of 104 cases. Arch Ophthalmol (1973) 1.41

Nonglaucomatous excavation of the optic disc. Arch Ophthalmol (1980) 1.37

Primate photopic sine-wave flicker ERG: vector modeling analysis of component origins using glutamate analogs. Invest Ophthalmol Vis Sci (2001) 1.36

Bilateral optic nerve compression as a mechanism for the Foster Kennedy syndrome. Ophthalmology (1989) 1.36

Brain biopsy in primary angiitis of the central nervous system. Neurology (1999) 1.35

Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene. Arch Ophthalmol (2000) 1.34

Dystrophic changes in the anterior cornea. Arch Ophthalmol (1972) 1.34

Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci (2000) 1.29

Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. Genomics (1999) 1.29

Remapping of the RP15 locus for X-linked cone-rod degeneration to Xp11.4-p21.1, and identification of a de novo insertion in the RPGR exon ORF15. Am J Hum Genet (2000) 1.28

Analysis of the RPGR gene in 11 pedigrees with the retinitis pigmentosa type 3 genotype: paucity of mutations in the coding region but splice defects in two families. Am J Hum Genet (1997) 1.25

Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol (1998) 1.25

Inner retinal contributions to the primate photopic fast flicker electroretinogram. J Opt Soc Am A Opt Image Sci Vis (1996) 1.23

Painful oculomotor palsy caused by posterior-draining dural carotid cavernous fistulas. Arch Ophthalmol (1995) 1.20

Perichiasmal tumors: diagnostic and prognostic features. Neurosurgery (1984) 1.20

Lens epithelium-derived growth factor promotes photoreceptor survival in light-damaged and RCS rats. Invest Ophthalmol Vis Sci (2001) 1.20

Optic nerve involvement in dysthyroidism. Ophthalmology (1981) 1.20

Refractive errors of retinitis pigmentosa patients. Br J Ophthalmol (1978) 1.20

Characterization of the rod photoresponse isolated from the dark-adapted primate ERG. Vis Neurosci (2001) 1.17

Bilateral macular atrophy in blue cone monochromacy (BCM) with loss of the locus control region (LCR) and part of the red pigment gene. Mol Vis (1999) 1.14

Analysis of photoreceptor function and inner retinal activity in juvenile X-linked retinoschisis. Vision Res (2001) 1.14

Third nerve palsy and the pupil. Footnotes to the rule. Arch Ophthalmol (1988) 1.13

Assessment of foveal cone photoreceptors in Stargardt's macular dystrophy using a small dot detection task. Vision Res (1993) 1.12

The scotopic threshold response of the cat ERG is suppressed selectively by GABA and glycine. Vision Res (1991) 1.10

Optic atrophy. Differential diagnosis by fundus observation alone. Arch Ophthalmol (1980) 1.09

Protein-truncation mutations in the RP2 gene in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet (1999) 1.09

Isolated pupil-sparing third nerve palsy. Ophthalmology (1985) 1.08

Quantitative perimetry in compressive optic neuropathy and optic neuritis. Arch Ophthalmol (1978) 1.07

The electroretinogram of the rhodopsin knockout mouse. Vis Neurosci (1999) 1.04

Meningiomas and aneurysms of the cavernous sinus. Neuro-ophthalmologic features. Arch Ophthalmol (1978) 1.02

A Colombian family with X-linked juvenile retinoschisis with three affected females finding of a frameshift mutation. Ophthalmic Genet (1999) 1.01

The melatonin antagonist luzindole protects retinal photoreceptors from light damage in the rat. Invest Ophthalmol Vis Sci (1998) 1.00

Preservation of inner retinal responses in the aged Royal College of Surgeons rat. Evidence against glutamate excitotoxicity in photoreceptor degeneration. Invest Ophthalmol Vis Sci (1995) 1.00

Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis. Hum Mol Genet (2010) 1.00

Pupil sparing in oculomotor palsy: a brief review. Ann Neurol (1983) 1.00

Acute macular neuroretinopathy: early receptor potential change suggests photoreceptor pathology. Br J Ophthalmol (1984) 0.98

Autosomal dominant macular atrophy at 6q14 excludes CORD7 and MCDR1/PBCRA loci. Invest Ophthalmol Vis Sci (2000) 0.96

Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats. Exp Eye Res (2000) 0.96

Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2000) 0.95

Leber's congenital amaurosis with marbelized fundus and juvenile nephronophthisis. Am J Ophthalmol (1989) 0.95

Structural and functional rescue of murine rod photoreceptors by human rhodopsin transgene. Hum Mol Genet (1999) 0.95

Aspartate separation of the scotopic threshold response (STR) from the photoreceptor a-wave of the cat and monkey ERG. Invest Ophthalmol Vis Sci (1988) 0.94

Disruption of conserved rhodopsin disulfide bond by Cys187Tyr mutation causes early and severe autosomal dominant retinitis pigmentosa. Ophthalmology (1995) 0.94

Spectrum of color gene deletions and phenotype in patients with blue cone monochromacy. Hum Genet (2000) 0.94

The effect of calcium channel blocker diltiazem on photoreceptor degeneration in the rhodopsin Pro213His rat. Invest Ophthalmol Vis Sci (2000) 0.93

Novel mutations in XLRS1 causing retinoschisis, including first evidence of putative leader sequence change. Hum Mutat (1999) 0.93

Common errors in the use of magnetic resonance imaging for neuro-ophthalmic diagnosis. Surv Ophthalmol (2000) 0.93

Managing oculomotor nerve palsy. Arch Ophthalmol (1998) 0.92

Proximal retinal contribution to the intraretinal 8-Hz pattern ERG of cat. J Neurophysiol (1987) 0.91

Shunt failure without ventriculomegaly proclaimed by ophthalmic findings. J Neurosurg (1994) 0.91

Cyclodeviation in acquired vertical strabismus. Arch Ophthalmol (1984) 0.90

Evidence for two sites of adaptation affecting the dark-adapted ERG of cats and primates. Vision Res (1995) 0.90

Upgaze paralysis caused by lesion of the periaqueductal gray matter. Arch Neurol (1984) 0.90

Bilateral optic canal meningiomas: a case report. Neurosurgery (1978) 0.88

An evaluation of the accuracy of community-based perimetry. Am J Ophthalmol (1980) 0.88

Fenestrated sheen macular dystrophy. Am J Ophthalmol (1991) 0.87

HLA and ophthalmic disease associations: a critical review and improved method for statistical analysis. Acta Ophthalmol (Copenh) (1982) 0.87

Varied clinical spectrum of necrobiotic xanthogranuloma. Ophthalmology (1992) 0.87

Evaluation of the ELOVL4 gene in patients with age-related macular degeneration. Ophthalmic Genet (2001) 0.87

Angle-closure glaucoma as initial presentation of myelodysplastic syndrome. Can J Ophthalmol (1990) 0.87

Integrative agnosia following progressive multifocal leukoencephalopathy. Cortex (1994) 0.87

Isolated oculomotor paralysis. The product of saccular and fusiform aneurysms of the basilar artery. Arch Ophthalmol (1978) 0.87

The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group. J Neuroophthalmol (1995) 0.86

Early receptor potential measurements in human ocular siderosis. Arch Ophthalmol (1983) 0.86

Looking behind the eyes. The proper use of modern imaging. Arch Ophthalmol (1993) 0.86

Long-term follow-up of a family with dominant X-linked retinitis pigmentosa. Eye (Lond) (2009) 0.86

Fifteen years of work: the COMS outcomes for medium-sized choroidal melanoma. Arch Ophthalmol (2001) 0.85

Rhodopsin Thr58Arg mutation in a family with autosomal dominant retinitis pigmentosa. Ophthalmology (1991) 0.85

Septic cavernous sinus thrombosis associated with gingivitis and parapharyngeal abscess. Arch Ophthalmol (1984) 0.85

Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene. Arch Ophthalmol (2000) 0.85

A recombination outside the BB deletion refines the location of the X linked retinitis pigmentosa locus RP3. Am J Hum Genet (1996) 0.85

X-linked juvenile retinoschisis: localization between (DXS1195, DXS418) and AFM291wf5 on a single YAC. Hum Hered (1997) 0.84

The peroxisome and the eye. Surv Ophthalmol (1991) 0.84

Foveal retinoschisis associated with senile retinoschisis in a woman. Am J Ophthalmol (1988) 0.84

Carotid endarterectomy. Who needs it? Ophthalmology (1987) 0.84